Editorial: Natural products as drivers in drug development for neurodegenerative disorders

Joana Silva; Rebeca Alvariño; Márcia I Goettert; Hector J Caruncho; Celso Alves

doi:10.3389/fphar.2022.932179

Editorial: Natural products as drivers in drug development for neurodegenerative disorders

Front Pharmacol. 2022 Aug 4:13:932179. doi: 10.3389/fphar.2022.932179. eCollection 2022.

Authors

Joana Silva¹, Rebeca Alvariño², Márcia I Goettert^{3

4}, Hector J Caruncho⁵, Celso Alves¹

Affiliations

¹ MARE-Marine and Environmental Sciences Centre, Polytechnic of Leiria, Peniche, Portugal.
² Department of Pharmacology, Faculty of Veterinary, University of Santiago de Compostela, Lugo, Spain.
³ Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls Universität Tübingen, Tübingen, Germany.
⁴ Cell Culture Laboratory, Postgraduate Programme in Biotechnology, University of Vale do Taquari Univates, Lajeado, Brazil.
⁵ Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.

No abstract available

Keywords: apoptosis; drug discovery; ethnopharmacology; mechanisms of action; natural products (NP); neuroinflammation; neuropharmacology; oxidative stress.

Publication types

Editorial